The effect of ageing on human lymphocyte subsets: Comparison of males and females

Immunity and Ageing

Volumn 7, Issue , 2010, Pages

  Yan, Jun ^a   Greer, Judith M ^a   Hull, Renee ^c   O'Sullivan, John D ^a,c   Henderson, Robert D ^a,c   Read, Stephen J ^c   McCombe, Pamela A ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WESLEY HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; LINEAR REGRESSION ANALYSIS; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PURIFICATION; SEX DIFFERENCE; T LYMPHOCYTE;

EID: 77952306780     PISSN: 17424933     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4933-7-4     Document Type: Article

References (71)

1. Pan WR, Suami H, Taylor GI. Senile changes in human lymph nodes. Lymphat Res Biol 2008, 6:77-83. 10.1089/lrb.2007.1023, 18564922.
2. Miller RA. Aging and immune function. Int Rev Cytol 1991, 124:187-215. full_text, 2001916.
3. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004, 5:133-139. 10.1038/ni1033, 14749784.
4. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007, 211:144-156. 10.1002/path.2104, 1931833, 17200946.
5. Pawelec G, Solana R. Immunosenescence. Immunol Today 1997, 18:514-516. 10.1016/S0167-5699(97)01145-6, 9386344.
6. Dorshkind K, Swain S. Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol 2009, 21:404-407. 10.1016/j.coi.2009.07.001, 19632102.
7. Stern S, Behar S, Gottlieb S. Cardiology patient pages. Aging and diseases of the heart. Circulation 2003, 108:e99-101. 10.1161/01.CIR.0000086898.96021.B9, 14530186.
8. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, Cockcroft JR, Wilkinson IB. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 2008, 51:1476-1482. 10.1161/HYPERTENSIONAHA.107.105445, 18426997.
9. Grubeck-Loebenstein B, Della BS, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009, 21:201-209.
10. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults?. Curr Opin Immunol 2009, 21:418-424. 10.1016/j.coi.2009.05.023, 19570667.
11. Tower J, Arbeitman M. The genetics of gender and life span. J Biol 2009, 8:38. 2688912, 19439039.
12. McCombe PA, Greer JM, Mackay IR. Sexual dimorphism in autoimmune disease. Current Molecular Medicine 2009,
13. Nunn CL, Lindenfors P, Pursall ER, Rolff J. On sexual dimorphism in immune function. Philos Trans R Soc Lond B Biol Sci 2009, 364:61-69. 10.1098/rstb.2008.0148, 2666693, 18926977.
14. Yan J, Greer JM, Etherington K, Cadigan GP, Cavanagh H, Henderson RD, O'sullivan JD, Pandian JD, Read SJ, McCombe PA. Immune activation in the peripheral blood of patients with acute ischemic stroke. J Neuroimmunol 2009, 206:112-117. 10.1016/j.jneuroim.2008.11.001, 19058859.
15. Miller RA. Effect of aging on T lymphocyte activation. Vaccine 2000, 18:1654-1660. 10.1016/S0264-410X(99)00502-2, 10689144.
16. Douziech N, Seres I, Larbi A, Szikszay E, Roy PM, Arcand M, Dupuis G, Fulop T. Modulation of human lymphocyte proliferative response with aging. Exp Gerontol 2002, 37:369-387. 10.1016/S0531-5565(01)00204-2, 11772524.
17. Jiang J, Gross D, Elbaum P, Murasko DM. Aging affects initiation and continuation of T cell proliferation. Mech Ageing Dev 2007, 128:332-339. 10.1016/j.mad.2007.02.002, 17383712.
18. De la Fuente M, Baeza I, Guayerbas N, Puerto M, Castillo C, Salazar V, Ariznavarreta C, Tresguerres JA. Changes with ageing in several leukocyte functions of male and female rats. Biogerontology 2004, 5:389-400. 10.1007/s10522-004-3201-8, 15609103.
19. Hong MS, Dan JM, Choi JY, Kang I. Age-associated changes in the frequency of naive, memory and effector CD8+ T cells. Mech Ageing Dev 2004, 125:615-618. 10.1016/j.mad.2004.07.001, 15491679.
20. Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev 2006, 127:274-281. 10.1016/j.mad.2005.11.001, 16352331.
21. Amadori A, Zamarchi R, De SG, Forza G, Cavatton G, Danieli GA, Clementi M, Chieco-Bianchi L. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995, 1:1279-1283. 10.1038/nm1295-1279, 7489409.
22. Facchini A, Mariani E, Mariani AR, Papa S, Vitale M, Manzoli FA. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol 1987, 68:340-347. 1542727, 3498573.
23. Gregg R, Smith CM, Clark FJ, Dunnion D, Khan N, Chakraverty R, Nayak L, Moss PA. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol 2005, 140:540-546. 10.1111/j.1365-2249.2005.02798.x, 1809384, 15932517.
24. Trzonkowski P, Szmit E, Mysliwska J, Mysliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol 2006, 119:307-316. 10.1016/j.clim.2006.02.002, 16545982.
25. Brusko TM, Hulme MA, Myhr CB, Haller MJ, Atkinson MA. Assessing the in vitro suppressive capacity of regulatory T cells. Immunol Invest 2007, 36:607-628. 10.1080/08820130701790368, 18161521.
26. Simone R, Zicca A, Saverino D. The frequency of regulatory CD3+CD8+. J Leukoc Biol 2008, 84:1454-1461. 10.1189/jlb.0907627, 18780874.
27. Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S. CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol 2006, 176:6586-6593.
28. Miller RA. Telomere diminution as a cause of immune failure in old age: an unfashionable demurral. Biochem Soc Trans 2000, 28:241-245.
29. Iancu EM, Speiser DE, Rufer N. Assessing ageing of individual T lymphocytes: Mission impossible?. Mech Ageing Dev 2007,
30. Goronzy JJ, Fujii H, Weyand CM. Telomeres, immune aging and autoimmunity. Exp Gerontol 2006, 41:246-251. 10.1016/j.exger.2005.12.002, 16427234.
31. Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, Forti P, Facchini A. Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing. Exp Gerontol 2003, 38:653-659. 10.1016/S0531-5565(03)00058-5, 12814800.
32. Lee WW, Nam KH, Terao K, Yoshikawa Y. Age-related telomere length dynamics in peripheral blood mononuclear cells of healthy cynomolgus monkeys measured by Flow FISH. Immunology 2002, 105:458-465. 10.1046/j.1365-2567.2002.01386.x, 1782682, 11985666.
33. Neri S, Pawelec G, Facchini A, Ferrari C, Mariani E. Altered expression of mismatch repair proteins associated with acquisition of microsatellite instability in a clonal model of human T lymphocyte aging. Rejuvenation Res 2008, 11:565-572. 10.1089/rej.2007.0639, 18484899.
34. Issa JP. Age-related epigenetic changes and the immune system. Clin Immunol 2003, 109:103-108. 10.1016/S1521-6616(03)00203-1, 14585281.
35. Franceschi C, Valensin S, Fagnoni F, Barbi C, Bonafe M. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp Gerontol 1999, 34:911-921. 10.1016/S0531-5565(99)00068-6, 10673145.
36. Mazzatti DJ, White A, Forsey RJ, Powell JR, Pawelec G. Gene expression changes in longterm culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence. Aging Cell 2007, 6:155-163. 10.1111/j.1474-9726.2007.00269.x, 2049045, 17286612.
37. Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, Attig S, Wikby A, Strindhall J, Franceschi C, Pawelec G. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007, 1114:23-35. 10.1196/annals.1396.043, 17986574.
38. Pita-Lopez ML, Gayoso I, Delarosa O, Casado JG, Alonso C, Munoz-Gomariz E, Tarazona R, Solana R. Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors. Immun Ageing 2009, 6:11. 10.1186/1742-4933-6-11, 2741428, 19715573.
39. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, van der ZL, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005, 66:13-20. 10.1016/j.humimm.2004.05.016, 15620457.
40. Wang J, Ioan-Facsinay A, van d V, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007, 37:129-138. 10.1002/eji.200636435, 17154262.
41. Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di PP, Lucchini G, Zanlari L, Passeri G, Zanni F, Chezzi C, Franceschi C, Sansoni P. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp Gerontol 2004, 39:1233-1243. 10.1016/j.exger.2004.04.004, 15288697.
42. Vescovini R, Biasini C, Fagnoni FF, Telera AR, Zanlari L, Pedrazzoni M, Bucci L, Monti D, Medici MC, Chezzi C, Franceschi C, Sansoni P. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol 2007, 179:4283-4291.
43. Miller JP, Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 2003, 171:2326-2330.
44. Kline GH, Hayden TA, Klinman NR. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol 1999, 162:3342-3349.
45. Johnson KM, Owen K, Witte PL. Aging and developmental transitions in the B cell lineage. Int Immunol 2002, 14:1313-1323. 10.1093/intimm/dxf092, 12407022.
46. Cancro MP, Smith SH. Peripheral B cell selection and homeostasis. Immunol Res 2003, 27:141-148. 10.1385/IR:27:2-3:141, 12857963.
47. Szabo P, Shen S, Telford W, Weksler ME. Impaired rearrangement of IgH V to DJ segments in bone marrow Pro-B cells from old mice. Cell Immunol 2003, 222:78-87. 10.1016/S0008-8749(03)00084-4, 12798310.
48. Frasca D, Nguyen D, Riley RL, Blomberg BB. Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. J Immunol 2003, 170:719-726.
49. King AM, Keating P, Prabhu A, Blomberg BB, Riley RL. NK cells in the CD19-B220+ bone marrow fraction are increased in senescence and reduce E2A and surrogate light chain proteins in B cell precursors. Mech Ageing Dev 2009, 130:384-392. 10.1016/j.mad.2009.03.002, 19428458.
50. Fagnoni FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G, Franceschi C, Passeri M, Sansoni P. Expansion of cytotoxic CD8+. Immunology 1996, 88:501-507. 10.1046/j.1365-2567.1996.d01-689.x, 1456634, 8881749.
51. Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells. Clin Immunol 2005, 115:10-18. 10.1016/j.clim.2005.02.018, 15870015.
52. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
53. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336. 10.1038/ni904, 12612578.
54. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39:537-545. 10.1136/jmg.39.8.537, 1735203, 12161590.
55. Tsaknaridis L, Spencer L, Culbertson N, Hicks K, LaTocha D, Chou YK, Whitham RH, Bakke A, Jones RE, Offner H, Bourdette DN, Vandenbark AA. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003, 74:296-308. 10.1002/jnr.10766, 14515359.
56. Bouman A, Schipper M, Heineman MJ, Faas MM. Gender difference in the non-specific and specific immune response in humans. Am J Reprod Immunol 2004, 52:19-26. 10.1111/j.1600-0897.2004.00177.x, 15214938.
57. Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 2000, 85:1648-1657. 10.1210/jc.85.4.1648, 10770211.
58. McCombe PA, Greer JM, Mackay IR. Sexual dimorphism in autoimmune disease. Curr Mol Med 2009, 9:1058-1079. 10.2174/156652409789839116, 19747114.
59. Ansar AS, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985, 121:531-551. 1887926, 3907369.
60. Weinstein Y, Ran S, Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol 1984, 132:656-661.
61. Terres G, Morrison SL, Habicht GS. A quantitative difference in the immune response between male and female mice. Proc Soc Exp Biol Med 1968, 127:664-667.
62. Kongshavn PA, Bliss JQ. Sex differences in survival of H-2 incompatible skin grafts in mice treated with antithymocyte serum. Nature 1970, 226:451. 10.1038/226451a0, 4909321.
63. Santoli D, Trinchieri G, Zmijewski CM, Koprowski H. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol 1976, 117:765-770.
64. Bebo BF, Adlard K, Schuster JC, Unsicker L, Vandenbark AA, Offner H. Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11. J Neurosci Res 1999, 55:432-440. 10.1002/(SICI)1097-4547(19990215)55:4<432::AID-JNR4>3.0.CO;2-2, 10723054.
65. Lotter H, Jacobs T, Gaworski I, Tannich E. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect Immun 2006, 74:118-124. 10.1128/IAI.74.1.118-124.2006, 1346632, 16368964.
66. Mock BA, Nacy CA. Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun 1988, 56:3316-3319. 259743, 3182082.
67. dos Santos CD, Toldo MP, do Prado Junior JC. Trypanosoma cruzi: the effects of dehydroepiandrosterone (DHEA) treatment during experimental infection. Acta Trop 2005, 95:109-115. 10.1016/j.actatropica.2005.05.005, 15955522.
68. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995, 26:1068-1079. 10.1016/0735-1097(95)00282-8, 7560601.
69. Cowell PE, Turetsky BI, Gur RC, Grossman RI, Shtasel DL, Gur RE. Sex differences in aging of the human frontal and temporal lobes. J Neurosci 1994, 14:4748-4755.
70. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M. Estrogen activates telomerase. Cancer Res 1999, 59:5917-5921.
71. Tower J. Sex-specific regulation of aging and apoptosis. Mech Ageing Dev 2006, 127:705-718. 10.1016/j.mad.2006.05.001, 16764907.